vimarsana.com
Home
Live Updates
Biosimilars Are Mighty, Can Help Alleviate Drug Spend Cost B
Biosimilars Are Mighty, Can Help Alleviate Drug Spend Cost B
Biosimilars Are Mighty, Can Help Alleviate Drug Spend Cost Burden
With the global market for biologics estimated at $382 billion just last year, and a projected global drug spend of close to $1.5 trillion by 2027, the landscape is ripe for biosimilars to help decrease the health care system’s cost burden.
Related Keywords
Ivo Abraham ,
Timothy Mok ,
University Of California San Francisco ,
Boehringer Ingelheim ,
Operational Readiness ,
Future Market ,
Clinic Administered ,
Specialty Medications ,
Kaiser Permanente Drug Use Management ,
California San ,
Biologics Price Competition ,
Innovation Act ,
Price Competition ,
Accessed April ,
Updated December ,
Cost Burden ,
Tiruximab ,
Infliximab ,
Biologics ,
Preference Products ,
Interchangeability ,